Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1977 Aug;57(4):769-78.
doi: 10.1016/s0039-6109(16)41287-9.

A Controlled Study of Combined Methotrexate, BCG, and INH Therapy for Squamous Cell Carcinoma of the Head and Neck

Clinical Trial

A Controlled Study of Combined Methotrexate, BCG, and INH Therapy for Squamous Cell Carcinoma of the Head and Neck

J E Woods et al. Surg Clin North Am. .

Abstract

In a randomized prospective study of patients with advanced squamous cell carcinoma of the head and neck, treatment with MTX plus BCG and with MTX plus BCG plus INH produced no better response rate or survival time than treatment with MTX alone.

Similar articles

See all similar articles

Publication types

MeSH terms

Feedback